Vaxart cans oral COVID-19 vaccine plans, lays off 27% of staff to go all in on norovirus program

Vaxart is pulling back from its oral COVID-19 vaccine program. | Vaxart is pulling back from its oral COVID-19 vaccine program. Rather than pump more money into the pandemic project, the oral recombinant vaccine specialist will prioritize its norovirus prospect, extending its cash runway and laying…